Enzymicals

Activities: Ingredients Pharmaceutical

Trending Articles

  1. IFF Pharma Solutions brings new innovations and excipient excellence to CPHI 2024 IFF Pharma Solutions is proud to announce its more than 75-year legacy as an excipient manufacturer with new product launches and technologies for the pharmaceutical and...
  2. Can artificial intelligence replicate the human touch in healthcare provision? Although most of the general chatter surrounding artificial intelligence (AI) can, most charitably, be dismissed as “uninformed,” there are already some encouraging signs...
  3. Data gathering developments As the use of RFID labelling spreads, the pharmaceutical industry is likely to see considerable benefits from this technology, says Richard Scott of SATO UK
  4. BD and ten23 health join forces to optimise aseptic injectable manufacturing The companies will track prefillable syringes using radio frequency identification (RFID) technology to boost supply chain visibility
  5. Actylis expands into VMS & Pharma with the acquisition of Pharm-Rx The acquisition strengthens Actylis’ presence in the VMS and OTC markets

Upcoming event

ISCC

15-18 October 2024 | Conference | Milan, Italy See all

Related Content

Research & Development

Experts discuss lyase for selective ring opening of di-substituted epoxides

Enzymicals scientists debate how to get one out of four: regio- and stereoselective ring opening of di-substituted epoxides catalysed by halohydrin dehalogenases

Enzymicals AG expands the online access to its products and services

Enzymicals expands the online access to its products and services via Science Exchange and Science.com
Ingredients

New enantioselective desymmetrisation strategy uses recombinant pig liver esterases

Enzymicals has established a new compound from the development of an efficient biocatalytic sequential multistep one-pot reaction

Enzymicals extends its capacity in business development
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Biocatalytic access to a novel class of Mannich catalysts

Dr Rainer Wardenga, Chief Scientific Officer at Enzymicals AG, discusses the synthesis of novel diastereomers of 5-benzyl-Ca-methyl-b-proline by the stereoselective hydrolysis of branched malonate diesters
Manufacturing

Synthetic approaches with Enzymicals recombinant pig liver esterases

Enzymicals provides biocatalytic access to a novel class of Mannich catalysts and a new bicyclic carboxylic acid ester
Ingredients

Enzymicals biocatalysts for straightforward synthesis of phosphorylated metabolites

Enzymicals AG provides a selection of highly active, long-term stable, regio- and enantioselective phosphotransferases/kinases to enable or simplify the production of enantiopure key metabolites and intermediates.
Subscribe now